IMAGING AGENTS
OA: closed
AI-generated summary
Compounds of formula (I) act as targeting vectors binding angiogenesis-associated receptors for the diagnosis or therapy of conditions including endometriosis, malignant diseases, and inflammation-related disorders.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The invention relates to compounds of formula (I): and their use as targetin g vectors that bind to receptors associated with angiogenesis. Such compounds may thus be used for diagnosis or therapy of, for example, malignant disease s, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-10-09T06:09:53.026058+00:00